Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
Wellington Management, Albion
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026 Formerly Spur Therapeutics | Toward More™ (freeline.life)
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…
XyloCorVenture round $23M · 5 yr ago
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our…
SomagenetixFounded 2019 • 51-200 employees
Ex-vivo gene therapy for phagocyte disorders. Somagenetix develops lentiviral HSC programs, starting with CGD—advancing safe, durable…
Atsena TherapeuticsSeries C $150M · 17 mo ago • 201-500 employees
Atsena is a clinical-stage gene therapy company, focused on bringing the life-changing power of genetic medicine to reverse or prevent…

Overview

Spur Therapeutics is a clinical-stage biotech that optimizes every component of its gene therapy candidates to change the course of diseases—and change lives.